Medindia
Medindia LOGIN REGISTER
Advertisement

Dry Eye Syndrome Market to Grow at 4% CAGR by 2019 from 2014 Worldwide

Saturday, August 29, 2015 Indian Health News
Advertisement
ReportsnReports.com adds dry eye syndrome market global report that provides pipeline analysis for Cyclokat, Diquas, EBI-005, MIM-D3, Lifitegrast, RGN-259, EBI-005 and EGP-437. The dry eye syndrome report, analysis market by sub-type of dry eye and drug type.
Advertisement



PUNE, Maharashtra, Aug. 28, 2015 /PRNewswire-iReach/ -- The Global Dry Eye Syndrome Market 2015-2019 report analysts forecast the global dry eye syndrome market to grow at a CAGR of 4.75% over the period 2014-2019.
Advertisement

Photo - http://photos.prnewswire.com/prnh/20150828/261876

Dry eye syndrome usually results in dryness of eyes due to deficient tear production or quick tear evaporation or deviation in tear uniformity. This syndrome is of two types: aqueous tear deficient dry eye and evaporative dry eye. In aqueous tear deficient dry eye, lacrimal glands do not produce enough tears, whereas meibomian gland dysfunction results in evaporative dry eye. Meibomian glands secrete lipids to slow tear evaporation and maintain tear stability. The symptoms include pain, redness, burning, and fatigue in the eye and decreased tolerance to continuous visual activity. Dry eye syndrome cannot be cured, but symptoms can be controlled. Teardrops and anti-inflammatory drugs are used in the treatment. Browse the 70 pages report at http://www.reportsnreports.com/reports/420124-global-dry-eye-syndrome-market-2015-2019.html, the report provides 34 Exhibits to support the research.The report includes the present scenario and the growth prospects of the global dry eye syndrome market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of teardrops and anti-inflammatory drugs used in the treatment of dry eye syndrome.The report, Global Dry Eye Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast as well as market segmentation. The report includes a discussion of the key vendors operating in this market.Key regions• Americas• APAC• EMEAKey vendors• Alcon• Allergan• Otsuka Holdings• Santen PharmaceuticalsOther prominent vendors• Acadia Pharmaceuticals                                                             • Aciex• Allostera Pharma• arGentis• Auven Therapeutics (Celtic)• Bridge Pharma• Can-Fite• Cellzome

Purchase a Copy of Report at http://www.reportsnreports.com/purchase.aspx?name=420124 - Single User License Copy of the report is US $2500.Key market driver• Growing prevalence of dry eye syndrome• For a full, detailed list, view our reportKey market challenge• Self-medication by patients• For a full, detailed list, view our reportKey market trend• Growing awareness about the syndrome• For a full, detailed list, view our reportKey questions answered in this report• What will the market size be in 2019 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key vendors?• What are the strengths and weaknesses of the key vendors?

Table of Contents PART 01: Executive summaryHighlights

PART 02: Scope of the reportMarket overviewTop-vendor offerings

PART 03: Market research methodologyResearch methodologyEconomic indicators

PART 04: IntroductionKey market highlights

PART 05: Disease overviewUnderstanding dry eye syndromeTypes of dry eye syndromeRisk factors for dry eye syndromeSigns and symptomsCauses of dry eye syndromeEpidemiologyDiagnosisDisease management

PART 06: Market landscapeMarket overviewMarket size and forecastFive forces analysis

PART 07: Pipeline analysisCyclokatDiquasEBI-005MIM-D3LifitegrastRGN-259EBI-005EGP-437

PART 08: Market segmentation by sub-type of dry eye

PART 09: Market segmentation by drug typeOral antibioticsEye dropsEye insertsEye ointmentsPART 10: Geographical segmentationMarket drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscapeCompetitive scenarioMarket share analysis 2014Other prominent vendors

PART 16: Key vendor analysisAlconAllerganOtsuka HoldingsSanten Pharmaceuticals

PART 17: AppendixList of abbreviations

PART 18: Explore TechnavioList of Exhibits Exhibit 01: Product offeringsExhibit 02: Regional prevalence of dry eye syndromeExhibit 03: Diagnosis of dry eye syndromeExhibit 04: Surgical optionsExhibit 05: Punctal plugsExhibit 06: Global dry eye syndrome market 2014-2019 ($ billions)Exhibit 07: Five forces analysisExhibit 08: Market segmentation by sub-type of dry eyeExhibit 09: Dry eye syndrome: pharmacologic therapyExhibit 10: Artificial tears: Different generationsExhibit 11: Global dry eye syndrome market share 2014Exhibit 12: Global dry eye syndrome: Key driversExhibit 13: Impact of driversExhibit 14: Global dry eye syndrome: Key challengesExhibit 15: Impact of drivers and challengesExhibit 16: Global dry eye syndrome: Emerging trendsExhibit 17: Global dry eye syndrome market share analysis 2014Exhibit 18: Alcon: Business strategyExhibit 19: Alcon: Distribution of sales by category 2014Exhibit 20: Alcon: Region-wise sales distribution 2014 ($ millions)Exhibit 21: Alcon: Region-wise sales distribution 2013 ($ millions)Exhibit 22: Systane: Global sales 2011-2014 ($ millions)Exhibit 23: Allergan: Business strategyExhibit 24: Eye care pharmaceuticals: Global sales 2011-2014 ($ millions)Exhibit 25: Restasis: Global sales 2011-2014 ($ millions)Exhibit 26: Santen Pharmaceuticals: Business strategyExhibit 27: Hyalein: Global sales 2011-2014 ($ millions)Exhibit 28: Diquas: Global sales 2011-2014 ($ millions)Exhibit 29: Prescription ophthalmics : Global sales 2011-2014 ($ millions)Exhibit 30: Alcon: Business segmentation 2014Exhibit 31: Allergan: Business segmentation by revenue 2014Exhibit 32: Allergan: Business segmentation by revenue 2013 and 2014 ($ millions)Exhibit 33: Allergan: Geographical segmentation by revenue 2014Exhibit 34: Santen Pharmaceutical: Business/Product segmentation 2014 by revenue

About Us:

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details at [email protected] This e-mail address is being protected from spambots. You need JavaScript enabled to view it and we would be happy to help you find the business intelligence that you need. ReportsnReports.com offers research studies on agriculture, energy and power, automotive, Semiconductor and Electronics, Manufacturing & Construction, chemicals, environment, medical devices, healthcare, food and beverages, water and much more.

Media Contact: Ritesh Tiwari, ReportsnReports.com, + 1 888 391 5441, [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Reports n Reports

Sponsored Post and Backlink Submission


Latest Press Release on Indian Health News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close